ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies is set to host TECHDAY, showcasing its cutting-edge ...

ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology ...

VICTORIA, British Columbia, November 04, 2024--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces the details ...

ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA),an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on ...

ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, ...

VICTORIA, British Columbia — ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces the details of its upcoming ...

Highlights,ImmunoPrecise Antibodies,(NASDAQ:IPA),contributes to a significant study on mitochondrial dysfunction.,The ...

VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology ...

ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces its significant contribution to a groundbreaking study.

Space is limited - secure your spot by contacting Jennifer K. Zimmons, PhD, MBA, at Quantum Media:[email protected] About ImmunoPrecise Antibodies Ltd. ImmunoPrecise Antibodies Ltd.is a ...

The study focuses on the development of antibodies that detect damaged mitochondria, which are more common as we age. ImmunoPrecise played a crucial role in this project by applying its proprietary ...